Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ryan
A Menter

Showing results (61-70 of 1,260) with videos related to

Pageof 126
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|March 21, 2012
Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension studyK Papp, A Menter, Y Poulin, et al.
Journal of the American Academy of Dermatology|September 1, 1989
Cyclosporine therapy for psoriasis: serum creatinine measurements are an unreliable predictor of decreased renal functionS C Gilbert, M Emmett, A Menter, et al.
International Journal of Dermatology|March 1, 1996
Psoriasis and pregnancy: hormone and immune system interactionA S Boyd, L F Morris, C M Phillips, et al.
Journal of the American Academy of Dermatology|May 1, 1991
Panniculitis in an immunocompromised patientA K Silverman, S C Gilbert, D Watkins, et al.
Journal of the American Academy of Dermatology|November 1, 1993
Methotrexate and reproduction in men: case report and recommendationsL F Morris, M J Harrod, M A Menter, et al.
Journal of Drugs in Dermatology : JDD|March 22, 2005
Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group studyA Shalita, B Miller, A Menter, et al.
The British Journal of Dermatology|June 13, 2008
Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trialsA K Brimhall, L N King, J C Licciardone, et al.
The British Journal of Dermatology|April 1, 2008
Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasisC Leonardi, A Menter, T Hamilton, et al.
Archives of Dermatology|March 20, 2001
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership surveyG Krueger, J Koo, M Lebwohl, et al.
Clinical and Experimental Dermatology|September 20, 2008
Methotrexate for psoriasis in the era of biological therapyR B Warren, R J G Chalmers, C E M Griffiths, et al.
Pageof 126

Showing results (61-70 of 1,260) with videos related to

Sort By:
Pageof 126
Journal of the European Academy of Dermatology and Venereology : JEADV|March 21, 2012
Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension studyK Papp, A Menter, Y Poulin, et al.
Journal of the American Academy of Dermatology|September 1, 1989
Cyclosporine therapy for psoriasis: serum creatinine measurements are an unreliable predictor of decreased renal functionS C Gilbert, M Emmett, A Menter, et al.
International Journal of Dermatology|March 1, 1996
Psoriasis and pregnancy: hormone and immune system interactionA S Boyd, L F Morris, C M Phillips, et al.
Journal of the American Academy of Dermatology|May 1, 1991
Panniculitis in an immunocompromised patientA K Silverman, S C Gilbert, D Watkins, et al.
Journal of the American Academy of Dermatology|November 1, 1993
Methotrexate and reproduction in men: case report and recommendationsL F Morris, M J Harrod, M A Menter, et al.
Journal of Drugs in Dermatology : JDD|March 22, 2005
Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group studyA Shalita, B Miller, A Menter, et al.
The British Journal of Dermatology|June 13, 2008
Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trialsA K Brimhall, L N King, J C Licciardone, et al.
The British Journal of Dermatology|April 1, 2008
Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasisC Leonardi, A Menter, T Hamilton, et al.
Archives of Dermatology|March 20, 2001
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership surveyG Krueger, J Koo, M Lebwohl, et al.
Clinical and Experimental Dermatology|September 20, 2008
Methotrexate for psoriasis in the era of biological therapyR B Warren, R J G Chalmers, C E M Griffiths, et al.
Pageof 126